https://orcid.org/0000-0002-1873-3048
References
- Seidell JC, Halberstadt J. The global burden of obesity and the challenges of prevention. Ann Nutr Metab. 2015; 66(2):7–12.
- Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer-viewpoint of the IARC Working Group. N Engl J Med. 2016;375(8):794–8.
- Moore LL, Bradlee ML, Singer MR, Splansky GL, Proctor MH, Ellison RC, Kreger BE. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord. 2004;28(4):559–67.
- Li H, Yang G, Xiang Y-B, Zhang X, Zheng W, Gao Y-T, Shu X-O. Body weight, fat distribution and colorectal cancer risk: a report from cohort studies of 134255 Chinese men and women. Int J Obes (Lond)). 2013;37(6):783–9.
- Naeem A, Tun AM, Guevara E. Molecular genetics and the role of molecularly targeted agents in metastatic colorectal carcinoma. J Gastrointest Canc. 2020;51(2):387–400.
- Kern L, Mittenbühler MJ, Vesting AJ, Ostermann AL, Wunderlich CM, Wunderlich FT. Obesity-induced TNFα and IL-6 signaling: The missing link between obesity and inflammation-driven liver and colorectal cancers. Cancers (Basel). 2018;11(1):24.
- Quail DF, Dannenberg AJ. The obese adipose tissue microenvironment in cancer development and progression. Nat Rev Endocrinol. 2019;15(3):139–54.
- Michelet X, Dyck L, Hogan A, Loftus RM, Duquette D, Wei K, Beyaz S, Tavakkoli A, Foley C, Donnelly R, et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nat Immunol. 2018;19(12):1330–40.
- Bähr I, Goritz V, Doberstein H, Hiller GGR, Rosenstock P, Jahn J, Pörtner O, Berreis T, Mueller T, Spielmann J, et al. Diet-induced obesity is associated with an impaired NK cell function and an increased colon cancer incidence. J Nutr Metab. 2017;2017:4297025.
- Viel S, Besson L, Charrier E, Marçais A, Disse E, Bienvenu J, Walzer T, Dumontet C. Alteration of Natural Killer cell phenotype and function in obese individuals. Clin Immunol. 2017;177:12–7.
- Mortara L, Gariboldi MB, Bosi A, Bregni M, Pinotti G, Guasti L, Squizzato A, Noonan DM, Monti E, Campiotti L. Vitamin D deficiency has a negative impact on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells. Targ Oncol. 2018;13(5):657–65.
- Park Y, Peterson LL, Colditz GA. The plausibility of obesity paradox in cancer-point. Cancer Res. 2018;78(8):1898–903.
- Shahjehan F, Merchea A, Cochuyt JJ, Li Z, Colibaseanu DT, Kasi PM. Body mass index and long-term outcomes in patients with colorectal cancer. Front Oncol. 2018;8:620.
- Ahmed D, Eide PW, Eilertsen IA, Danielsen SA, Eknaes M, Hektoen M, Lind GE, Lothe RA. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. 2013;2(9):e71.
- Pantano F, Guida FM, Vivaldi C, Vincenzi B, Grande E, Garrote MR, Caraglia M, Silvestris N, Vasile E, Masi G, et al. Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment. Cancer Biol Ther. 2013;14(6):467–8.